Helicobacter Pylori
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2720-2725
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2720
Table 1 Effect of sample storage.
H pylori positivepatientsD1
D2
Rh123 MFRh123+CsA MFRMFRh123 MFRh123+CsA MFRMF
173.14124.581.70325.0044.761.790
275.2517.860.23727.834.280.157
35.4720.853.40417.2541.722.419
483.40113.791.36443.0361.201.423
583.40113.791.36490.44172.181.920
6141.2168.470.48572.9180.631.106
772.31223.193.08746.72223.444.783
8262.30220.780.842308.4326.901.06
9135.5393.900.69336.71255.956.972
10170.21225.351.324220.95223.711.012
11115.20165.201.43437.8894.262.288
1211.3025.102.22125.76134.785.332
RMF (mean±SD)1.427±1.0342.522±2.067
Table 2 Role of pretherapeutic determination of Pgp activity.
VariablesTherapy cycle
B/A and controls
H pylori positive
H pylorinegative
1 = A (n = 20)2 or more = B (n = 33)NO (n = 12)PaBeta Pb
Age (yr)47.5±8.847.3±13.748.3±16.50.9730.152
Sex (M/ F)9/1115/185/70.9750.153
DHP2.75±0.912.90±0.971.0±0.00.000010.00065
DIEn2.65±0.813.06±0.861.0±0.00.000010.45
RMF (mean±SD)0.889±0.281.647±0.650.787±0.290.000010.000005
Table 3 Impact of initial values on H pylori eradication efficacy.
VariableFinal eradication of H pylori
P
Successful (n = 31)Unsuccessful (n = 22)
Age (yr)46.54±12.5148.54±11.440.556
Sex (M/F)15/169/130.598
DHP2.90±0.972.77±0.920.626
DIEn2.77±0.8463.09±0.860.189
RMF (mean±SD)1.26±07151.54±0.660.13418